NLRP3 and lung carcinoma: It was reported that LPS+ATP induced activation of NLRP3 inflammasome in A549 lung cancer cells, and NLRP3 inflammasome activation enhanced the proliferation and migration of A549 cells by secreting IL-1β and IL-18 (17).